In addition to the positive effects of CB2 agonist on bone formation and its protective roles on osteoblast during osteoblast‐breast cancer interaction, the anticancer effects of CB2 agonists were also reported in many cancers [23, 40, 41, 42]. This evidence concerns the gene CNR2 and breast carcinoma.